New guidelines emphasize timely risk assessment and genetic testing for hereditary colorectal polyposis syndromes to significantly reduce cancer risk.

• Early identification through family history and genetic testing is crucial for patients at risk.
• The guidelines offer clear recommendations for surgical and endoscopic interventions to mitigate cancer incidence.

Surgeons should integrate these recommendations into practice to structure patient management and follow-up, focusing on those with phenotypic expressions or familial risk.